Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Med Genet B Neuropsychiatr Genet ; 126B(1): 99-105, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-15048657

ABSTRACT

The study of neurogenetic microdeletion syndromes provides an insight into the developmental psychopathology of psychiatric disorders. The aim of the study was to evaluate the prevalence of psychiatric disorders, especially obsessive-compulsive disorder (OCD), in patients with velocardiofacial syndrome (VCFS), a 22q11 microdeletion syndrome. Forty-three subjects with VCFS of mean age 18.3 +/- 10.6 years were comprehensively assessed using semi-structured psychiatric interview and the Yale-Brown obsessive compulsive scale (Y-BOCS). Best estimate diagnoses were made on the basis of information gathered from subjects, parents, teachers, and social workers. Fourteen VCFS subjects (32.6%) met the DSM-IV criteria for OCD. OCD had an early age of onset and generally responded to fluoxetine treatment. It was not related to mental retardation. The most common obsessive-compulsive symptoms were contamination, aggression, somatic worries, hoarding, repetitive questions, and cleaning. Sixteen of the 43 patients (37.2%) had attention-deficit/hyperactivity disorder (ADHD), and 7 (16.2%) had psychotic disorder. The results of our study suggest that there is a strong association between VCFS and early-onset OCD. This finding may be significant in the understanding of the underlying genetic basis of OCD.


Subject(s)
Chromosomes, Human, Pair 22/genetics , Craniofacial Abnormalities/genetics , Gene Deletion , Heart Defects, Congenital/genetics , Obsessive-Compulsive Disorder/genetics , Velopharyngeal Insufficiency/genetics , Adolescent , Adult , Child , Craniofacial Abnormalities/complications , Craniofacial Abnormalities/psychology , Female , Fluoxetine/therapeutic use , Heart Defects, Congenital/complications , Heart Defects, Congenital/psychology , Humans , In Situ Hybridization, Fluorescence , Male , Obsessive-Compulsive Disorder/drug therapy , Obsessive-Compulsive Disorder/psychology , Prevalence , Psychiatric Status Rating Scales , Selective Serotonin Reuptake Inhibitors/therapeutic use , Syndrome , Velopharyngeal Insufficiency/complications , Velopharyngeal Insufficiency/psychology
2.
Am J Med Genet B Neuropsychiatr Genet ; 126B(1): 116-21, 2004 Apr 01.
Article in English | MEDLINE | ID: mdl-15048660

ABSTRACT

Velocardiofacial syndrome (VCFS) is a relatively common developmental neuropsychiatric syndrome caused by a 22q11 microdeletion. There is an extensive variability in the phenotypic expression of this disease. The most common psychiatric disorder in VCFS is attention-deficit/hyperactivity disorder (ADHD), affecting 35-55% of patients. This study investigated the association of familial, developmental, and physical factors with the occurrence of ADHD in 51 patients with nonfamilial VCFS. Twenty-one patients (41.2%) were diagnosed with ADHD. There was a significantly greater prevalence of ADHD in the first-degree relatives of the patients with ADHD than in those without (OR = 5.9, 95% CI = 1.6-22.1, P = 0.006). No differences were noted between the ADHD and non-ADHD groups in mean Obstetric Complication Scale Score, gestational age, birth weight, age at first words, walking, and achieving bowel control. The two groups also had similar IQ scores (total, verbal, and performance) and had a similar average degree of severity of facial dysmorphism and cardiac and cleft anomalies. These findings indicate that ADHD in VCFS has a genetic contribution and the patients' VCFS-related developmental factors and physical illnesses play a lesser role.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Chromosomes, Human, Pair 22/genetics , Cleft Palate/genetics , Craniofacial Abnormalities/genetics , Heart Defects, Congenital/genetics , Personality/genetics , Velopharyngeal Insufficiency/genetics , Adolescent , Adult , Attention Deficit Disorder with Hyperactivity/drug therapy , Child , Developmental Disabilities , Female , Humans , Intelligence , Male , Neuropsychological Tests , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...